Stay updated on Expanded Access Risdiplam in SMA Clinical Trial
Sign up to get notified when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.

Latest updates to the Expanded Access Risdiplam in SMA Clinical Trial page
- CheckyesterdayChange DetectedAdded site revision note Revision: v3.4.2 and removed the funding/operating status notices; overall study content remains unchanged.SummaryDifference0.4%

- Check8 days agoChange DetectedAdded a site-wide notice informing users that, due to a lapse in government funding, information may not be up to date and transactions may not be processed. Also updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page now shows a glossary (Show glossary), includes a new revision indicator (v3.4.0), and contains minor capitalization tweaks in QC-related labels (e.g., 'Met QC Criteria' vs 'met QC Criteria' and 'Data' vs 'data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page adds Revision: v3.3.4 and removes Revision: v3.3.3.SummaryDifference0.1%

- Check50 days agoChange DetectedExpanded Locations section now lists additional U.S. sites (Arkansas, California, Colorado, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Massachusetts, Michigan, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Virginia, Wisconsin) and includes a Revision: v3.3.3. The previous location list and the HHS Vulnerability Disclosure entry have been removed.SummaryDifference2%

- Check79 days agoChange DetectedAn addition updates the Publications section to note that PubMed-derived publications are automatically filled and may not all pertain to the study (Revision: v3.3.2). A corresponding deletion updates the wording to indicate publications are auto-generated by ClinicalTrials.gov using the NCT number and may not be about the study (Revision: v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Expanded Access Risdiplam in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.